<?xml version="1.0" encoding="UTF-8"?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1" xml:lang="zh" xsi:noNamespaceSchemaLocation="https://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1.xsd"><front><journal-meta><!-- 出版商赋予期刊ID--><journal-id journal-id-type="publisher-id">YIKE</journal-id><journal-title-group><!-- 期刊中文全称--><journal-title>安徽医科大学学报</journal-title><!-- 期刊英文全称--><journal-title xml:lang="en">Acta Universitatis Medicinalis Anhui</journal-title><!-- 期刊英文缩写--><abbrev-journal-title abbrev-type="publisher" xml:lang="en">Acta Universitatis Medicinalis Anhui</abbrev-journal-title><!-- 期刊中文缩写--><abbrev-journal-title abbrev-type="publisher">安徽医科大学学报</abbrev-journal-title></journal-title-group><!-- 期刊ISSN号--><issn pub-type="ppub">1000-1492</issn><!-- 期刊CN号--><issn pub-type="cn">34-1065/R</issn><publisher><!--出版商英文名称【预置实体】 待确认 --><publisher-name xml:lang="en">Anhui Lianzhong Printing Limited Company</publisher-name><!--出版商英文地址【预置实体】 --><publisher-loc xml:lang="en">Editorial Board of Acta Universitatis Medi-cinalis Anhui Meishan Road , Hefei 230032</publisher-loc><!-- 出版商中文名称【预置实体】--><publisher-name>《安徽医科大学学报》编辑部</publisher-name><!--出版商中文地址【预置实体】 --><publisher-loc>安徽省合肥市安徽医科大学校内老图书馆三楼</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1000–1492（2026）04–0699–07</article-id><article-id pub-id-type="doi">10.19405/j.cnki.issn1000–1492.2026.04.014</article-id><article-id pub-id-type="manuscript">6 V235 刘焕 </article-id><article-categories><subj-group subj-group-type="clc"><subject>R541.6</subject></subj-group><subj-group subj-group-type="dc"><subject>A</subject></subj-group><subj-group subj-group-type="heading"><subject>基础医学研究</subject></subj-group></article-categories><title-group><article-title>TLR4介导的NETs形成在异丙肾上腺素诱导的老龄小鼠心力衰竭中的作用</article-title><trans-title-group xml:lang="en"><trans-title>Role of TLR4-mediated NETs formation in isoproterenol-induced heart failure in aged mice</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name name-style="eastern"><surname>刘</surname><given-names>焕</given-names></name><name name-style="eastern" xml:lang="en"><surname>Liu</surname><given-names>Huan</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="author-notes" rid="fna1"/></contrib><contrib contrib-type="author"><name-alternatives><name name-style="eastern"><surname>陈</surname><given-names>向东</given-names></name><name name-style="eastern" xml:lang="en"><surname>Chen</surname><given-names>Xiangdong</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern"><surname>吴</surname><given-names>志林</given-names></name><name name-style="eastern" xml:lang="en"><surname>Wu</surname><given-names>Zhilin</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1"/><xref ref-type="author-notes" rid="fna2"/></contrib><aff-alternatives id="aff1"><aff><label>1</label><institution>华中科技大学同济医学院附属协和医院，麻醉科</institution>、，<city>武汉</city>  <postal-code>430022</postal-code></aff><aff xml:lang="en"><label>1</label><institution>Dept of Anesthesiology</institution>，</aff></aff-alternatives><aff-alternatives id="aff2"><aff><label>2</label><institution>华中科技大学同济医学院附属协和医院，麻醉与危重病研究所</institution>，<city>武汉</city>  <postal-code>430022</postal-code></aff><aff xml:lang="en"><label>2</label><institution>Institute of Anesthesia and Critical Care Medicine， Union Hospital，  Tongji Medical College， Huazhong University of Science and Technology</institution>， <city>Wuhan</city>     <postal-code>430022</postal-code></aff></aff-alternatives><aff-alternatives id="aff3"><aff><label>3</label><institution>麻醉复苏教育部重点实验室（华中科技大学），武汉  430022</institution></aff><aff xml:lang="en"><label>3</label><institution>Key Laboratory of Anesthesiology and Resuscitation， Ministry of Education， Huazhong University  of Science and Technology</institution>， <city>Wuhan</city>     <postal-code>430022</postal-code></aff></aff-alternatives></contrib-group><author-notes><corresp xml:lang="en" id="cor1"><named-content content-type="corresp-name">Wu Zhilin</named-content>， E-mail： <email>840916@qq.com</email></corresp><fn fn-type="other" specific-use="about-author" id="fna1"><p><named-content content-type="corresp-name">刘  焕</named-content>，女，主治医师</p></fn><fn fn-type="other" specific-use="about-author" id="fna2"><p><named-content content-type="corresp-name">吴志林</named-content>，男，博士，副主任医师，通信作者，E-mail： 840916 @qq.com</p></fn></author-notes><pub-date pub-type="epub" iso-8601-date="2026-02-09T17：33：47"><day>09</day><month>02</month><year>2026</year></pub-date><pub-date pub-type="ppub"><day>23</day><month>04</month><year>2026</year></pub-date><volume>61</volume><issue>4</issue><issue-id>15</issue-id><fpage>699</fpage><lpage>705</lpage><page-range>699-705</page-range>  <history><date date-type="received">        <day>13</day><month>01</month><year>2026</year></date></history><abstract abstract-type="key-points"><sec><title>目的</title><p>探讨Toll样受体4（TLR4）介导的中性粒细胞胞外诱捕网（NETs）形成对异丙肾上腺素（ISO）诱导的老龄小鼠心力衰竭（HF）的作用。</p></sec><sec><title>方法</title><p>将小鼠随机分为Control组、Model组、TAK-242（TLR4抑制剂）组、LPS（TLR4激动剂）组和LPS+DNaseⅠ（NETs抑制剂）组，每组8只。通过渗透泵持续输注ISO建立HF模型，输注最后1周给予TAK-242、LPS和LPS+DNaseⅠ干预，连续7 d。采用小动物超声系统评估各组小鼠心功能变化；ELISA法检测各组小鼠血清中N末端B型利钠肽原（NT-pro BNP）、心肌肌钙蛋白I（cTn I）、白细胞介素（IL）-1β、IL-6、肿瘤坏死因子α（TNF-α）及血清和心肌组织中髓过氧化物酶-DNA（MPO-DNA）、中性粒细胞弹性蛋白酶-DNA（NE-DNA）水平；HE染色观察各组小鼠心肌组织病理学变化；Masson染色观察各组小鼠心肌组织胶原纤维的沉淀情况；免疫荧光观察小鼠心肌组织中Ly6G与MPO共定位水平；Western blot检测各组小鼠心肌组织中TLR4、MPO、NE、cit-H3蛋白表达量。</p></sec><sec><title>结果</title><p>与Control组比较，Mode组小鼠舒张末期室间隔厚度（IVSD）、左心室舒张末期内径（LVEDD）、左心室收缩末期内径（LVESD）升高（<italic>P</italic>&lt;0.01），短轴缩短率（FS）和射血分数（EF）降低（<italic>P</italic>&lt;0.01），心肌结构明显受损，心肌组织胶原纤维的沉淀增加，血清中NT-pro BNP、cTnI、IL-1β、IL-6、TNF-α含量升高（<italic>P</italic>&lt;0.01），血清及心肌组织中MPO-DNA和NE-DNA含量升高（<italic>P</italic>&lt;0.01），心肌组织中Ly6G与MPO共定位水平及TLR4、MPO、NE、cit-H3等蛋白表达量均增加（<italic>P</italic>&lt;0.01）。TAK-242干预后上述指标显著逆转，而LPS组损伤进一步加剧。DNaseⅠ处理可部分缓解LPS诱导的心肌结构及功能恶化。</p></sec><sec><title>结论</title><p>TLR4及NETs在老龄HF小鼠心肌组织中异常增多。给予TLR4抑制剂TAK-242干预可抑制NETs的形成，降低炎症反应，改善老龄HF小鼠心功能。</p></sec></abstract><trans-abstract abstract-type="key-points" xml:lang="en"><sec><title>Objective</title><p>To examine the impact of Toll-like receptor 4 （TLR4）-mediated neutrophil extracellular traps （NETs） formation on isoproterenol （ISO）-induced heart failure （HF） in aged mice.</p></sec><sec><title>Methods</title><p>The mice were randomly divided into Control group， Model group， TAK-242 （TLR4 inhibitor） group， LPS （TLR4 agonist） group and LPS+DNaseⅠ （NETs inhibitor） group， with 8 mice in each group. The HF model was established by continuous infusion of ISO through an osmotic pump， and TAK-242， LPS， and LPS+DNaseⅠ interventions were administered during the last week of infusion for 7 consecutive days. ELISA was used to detect the N-terminal pro-B-type natriuretic peptide （NT-pro BNP）， cardiac troponin I （cTnI）， interleukin-1β （IL-1β）， interleukin-6 （IL-6）， tumor necrosis factor-α （TNF-α）， and serum and myocardial tissue myeloperoxidase-DNA （MPO-DNA） and neutrophil elastase-DNA （NE-DNA） levels. HE staining was used to observe the pathological changes of myocardial tissue. Masson staining was used to observe the deposition of collagen fibers in myocardial tissue. Immunofluorescence was used to observe the colocalization of Ly6G and MPO in myocardial tissue. The protein expressions of TLR4， MPO， NE and cit-H3 in myocardial tissue were detected by Western blot.</p></sec><sec><title>Results</title><p>Compared with the Control group， the end-diastolic interventricular septal thickness （IVSD）， left ventricular end-diastolic diameter （LVEDD） and left ventricular end-systolic diameter （LVESD） in the Mode group significantly increased （<italic>P</italic>&lt;0.01）， fractional shortening （FS） and ejection fraction （EF） significantly decreased （<italic>P</italic>&lt;0.01）， and the myocardial structure was significantly damaged. The myocardial collagen fiber precipitation， serum NT-pro BNP， cTnI， IL-1β， IL-6 and TNF-α contents， MPO-DNA and NE-DNA contents in serum and myocardial tissue significantly increased （<italic>P</italic>&lt;0.01）. The co-localization of Ly6G and MPO and the expression of TLR4， MPO， NE and cit-H3 proteins in myocardial tissue significantly increased （<italic>P</italic>&lt;0.01）. After TAK-242 intervention， the above indicators were significantly reversed， while the injury was further aggravated in LPS group. DNaseⅠ treatment could partially alleviate the deterioration of myocardial structure and function induced by LPS.</p></sec><sec><title>Conclusion</title><p>TLR4 and NETs are abnormally elevated in the myocardial tissue of aged HF mice. Treatment with the TLR4 inhibitor TAK-242 effectively suppresses NET formation， attenuates inflammatory responses， and enhances cardiac function in aged HF mice.</p></sec></trans-abstract><kwd-group kwd-group-type="author"><kwd>心力衰竭</kwd><kwd>Toll样受体4</kwd><kwd>中性粒细胞胞外诱捕网</kwd><kwd>炎症</kwd><kwd>异丙肾上腺素</kwd><kwd>心血管疾病</kwd></kwd-group><kwd-group xml:lang="en" kwd-group-type="author"><kwd>heart failure</kwd><kwd>Toll like receptor 4</kwd><kwd>neutrophil extracellular traps</kwd><kwd>inflammation</kwd><kwd>isoproterenol</kwd><kwd>cardiovascular diseases</kwd></kwd-group><funding-group><award-group><funding-source>湖北省自然科学基金项目</funding-source><award-id>2025AFB760</award-id></award-group><funding-statement>湖北省自然科学基金项目（编号： 2025AFB760）</funding-statement></funding-group><funding-group xml:lang="en"><award-group><funding-source>Fund program  Natural Science Foundation of Hubei Province</funding-source><award-id>2025AFB760</award-id></award-group><funding-statement>Natural Science Foundation of Hubei Province （No. 2025AFB760）</funding-statement></funding-group><counts><fig-count count="7"/><table-count count="0"/><equation-count count="0"/><ref-count count="15"/><page-count count="7"/><word-count count="16192"/></counts><custom-meta-group><custom-meta><meta-name>version</meta-name><meta-value>1.0.0.25071</meta-value></custom-meta><custom-meta><meta-name>structure-time</meta-name><meta-value>2026-05-28T11:37:37</meta-value></custom-meta><custom-meta><meta-name>word-source</meta-name><meta-value>FX</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>心力衰竭（heart failure， HF）是一种因心脏结构或功能异常引发的临床危重综合征，主要表现为心室充盈或射血功能障碍，导致心脏泵血量无法满足机体代谢需求，并伴随呼吸困难、心悸及体液潴留等症状。HF病因多样，可继发于多种心脏疾病。HF在65岁及以上的老年群体中呈现高发病率和高死亡风险，是心血管类疾病研究的重点及难点。HF的发病因素复杂，常伴有炎症反应及免疫功能异常。Toll样受体（Toll like receptor， TLR）是模式识别受体（pattern recognition receptor， PRR）家族的一员，可以识别病原体相关分子模式和损伤相关分子模式，以激发先天免疫反应，从而导致急性或慢性炎症<sup>［<xref ref-type="bibr" rid="R1">1</xref>］</sup>。课题组前期研究<sup>［<xref ref-type="bibr" rid="R2">2</xref>］</sup>表明，TLR4在老年HF小鼠的心脏中表达显著上调，TLR4缺失可增加老年小鼠的胰岛素敏感性，改善心脏功能和内皮依赖性老年小鼠的血管松弛，抑制心脏和主动脉的氧化应激，减少炎症反应和氧化应激。中性粒细胞是机体重要的免疫细胞，参与机体各种生理病理过程，而中性粒细胞胞外诱捕网（neutrophil extracellular traps， NETs）是由中性粒细胞的DNA、组蛋白和细胞毒性颗粒衍生蛋白等构成的网状结构，参与人体诸多疾病进程。作为先天免疫反应的主要组成部分，NETs已被证实在心血管疾病中发挥重要作用。Zhao et al<sup>［<xref ref-type="bibr" rid="R3">3</xref>］</sup>研究发现，抗炎糖蛋白内皮细胞发育调节蛋白1缺乏可通过促进中性粒细胞浸润和NETs形成而加重压力超负荷诱导的HF。同时有研究<sup>［<xref ref-type="bibr" rid="R4">4</xref>］</sup>显示，在炎症和感染过程中，TLR4的激活对NETs的释放具有显著影响，提示TLR4表达上调可能通过促进NETs形成，加重老年性HF的进展。因此，该研究通过建立HF老龄小鼠模型，拟探讨TLR4介导的NETs形成在HF中的作用，以期为老年心脏病的治疗提供新思路。</p><sec id="s1"><label>1</label><title>材料与方法</title><sec id="s1a"><label>1.1</label><title>材料</title><sec id="s1a1"><label>1.1.1</label><title>实验动物</title><p specific-use="noneIndent">本研究选用18月龄（老龄）雄性C57BL/6J小鼠40只，体质量30~35 g，购自三峡大学实验动物中心，动物生产许可证号：SCXK（鄂）2022-0012。饲养环境：温度22 ℃±2 ℃，相对湿度50%±5%，昼夜光照各12 h循环照明，动物自由进食、饮水。实验获得华中科技大学实验动物伦理委员会的批准（批准号：IACUC-2024-4865）。</p></sec><sec id="s1a2"><label>1.1.2</label><title>主要试剂</title><p specific-use="noneIndent">异丙肾上腺素（isoproterenol， ISO）、TAK-242、脂多糖（lipopolysaccharides， LPS）、DNaseⅠ购自美国MedChemExpress公司；小鼠N末端B型利钠肽原（N-terminal pro-B-type natriuretic peptide， NT-pro BNP）、心肌肌钙蛋白I（cardiac troponin I， cTnI）、白细胞介素（interleukin， IL）-1β、IL-6、肿瘤坏死因子α（tumor necrosis factor-α， TNF-α）ELISA检测试剂盒购自上海酶联生物；小鼠髓过氧化物酶（myeloperoxidase， MPO）-DNA和中性粒细胞弹性蛋白酶（neutrophil elastase， NE）-DNA ELISA检测试剂盒购自武汉赛培生物科技有限公司；Ly6G、MPO、TLR4、NE、瓜氨酸化组蛋白H3（citrullinated histone H3， cit-H3）抗体购自美国CST公司。</p></sec></sec><sec id="s1b"><label>1.2</label><title>方法</title><sec id="s1b1"><label>1.2.1</label><title>实验分组及HF模型制备</title><p specific-use="noneIndent">选取40只C57BL/6J小鼠随机分成Control组、Model组、TAK-242（TLR4抑制剂）组、LPS（TLR4激动剂）组和LPS+DNaseⅠ（NETs抑制剂）组，每组8只。除Control组外，其余各组小鼠均采用皮下注射ISO诱导HF小鼠模型，即腹腔注射0.3% 戊巴比妥钠溶液（50 mg/kg）麻醉小鼠，于小鼠背部皮下植入渗透微型泵，持续输注ISO 3周［30 mg/（kg·d），溶解于0.002%抗坏血酸溶液］，而Control组小鼠植入渗透微型泵后等量输注0.002% 抗坏血酸溶液。</p></sec><sec id="s1b2"><label>1.2.2</label><title>给药干预</title><p specific-use="noneIndent">渗透泵输注ISO的最后1周，TAK-242组、LPS组和LPS+DNaseⅠ组小鼠分别腹腔注射TAK-242（2 mg/kg，1次/d）、LPS（3.12 μg/只/d）和DNaseⅠ（50 μg/只/d），而Control组和Model组腹腔注射等量生理盐水，连续7 d。</p></sec><sec id="s1b3"><label>1.2.3</label><title>心功能指标检测</title><p specific-use="noneIndent">麻醉前12 h小鼠禁食不禁水，小鼠麻醉后以仰卧位固定于操作台，剔除前胸毛发，采用小动物超声系统，于左心室长轴切面水平采集M型超声心动图，测量舒张末期室间隔厚度（interventricular septal thickness， IVSD）、左心室舒张末期内径（left ventricular end-diastolic diameter， LVEDD）、左心室收缩末期内径（left ventricular end-systolic diameter， LVESD）结果均测量3个心动周期，取平均值，并计算短轴缩短率（fractional shortening， FS）和射血分数（ejection fraction， EF）。</p></sec><sec id="s1b4"><label>1.2.4</label><title>ELISA法检测</title><p specific-use="noneIndent">心功能检测结束后，小鼠经眼球取血，血液样本以3 000 r/min离心15 min，收集上清液待测。取血后颈椎脱臼处死小鼠，迅速摘取心脏，清洗残留血液后取部分组织与PBS混合后匀浆，组织匀浆液离心收集上清液待测。按照ELISA检测试剂盒说明书，450 nm波长检测吸光度（absorbance， <italic>A</italic>）值。计算各组小鼠血清中NT-pro BNP、cTnI、IL-1β、IL-6、TNF-α水平，以及血清和心肌组织中MPO-DNA和NE-DNA水平。</p></sec><sec id="s1b5"><label>1.2.5</label><title>HE染色和Masson染色</title><p specific-use="noneIndent">取心肌组织置于4% 多聚甲醛溶液中固定48 h后进行石蜡包埋，制作切片。组织切片遵循HE和Masson染色试剂盒说明书进行染色，观察各组小鼠心肌组织病理学变化和胶原纤维的沉淀情况，拍照留存。</p></sec><sec id="s1b6"><label>1.2.6</label><title>免疫荧光</title><p specific-use="noneIndent">取心肌组织置于4%多聚甲醛溶液中固定24 h后进行OCT包埋。切片加入0.5% Triton X-100浸泡15 min，10%山羊血清封闭2 h，加入一抗（Ly6G、MPO，1∶500）4 ℃孵育过夜，PBS清洗3次，避光环境下加入荧光素标记的二抗，室温孵育2 h，弃去二抗加入DAPI，室温孵育15 min，PBS清洗3次后封片，荧光显微镜下观察并拍照。</p></sec><sec id="s1b7"><label>1.2.7</label><title>Western blot检测</title><p specific-use="noneIndent">取心肌组织，与RIPA组织裂解液混合后匀浆，遵循RIPA试剂盒说明书抽提蛋白，BCA法检测蛋白浓度。上样后进行SDS-PAGE电泳、转膜，5%脱脂奶粉室温封闭1 h，TBST洗膜3次，加入一抗（TLR4、MPO、NE、cit-H3、GAPDH，1∶1 000）4 ℃ 冰箱孵育过夜。TBST洗膜3次，加入HRP标记的山羊抗兔二抗（1∶3 000），室温孵育1 h。ECL化学发光法显色，条带经ImageJ软件分析得出TLR4、MPO、NE、cit-H3蛋白表达量。</p></sec></sec><sec id="s1c"><label>1.3</label><title>统计学处理</title><p specific-use="noneIndent">采用SPSS 26.0和GraphPad Prism 8.0进行数据分析和图表绘制。结果均以均数±标准差（<inline-formula><alternatives><mml:math id="M1"><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo>±</mml:mo><mml:mi>s</mml:mi></mml:math><graphic specific-use="big" xlink:href="alternativeImage/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-M001.jpg"><?fx-imagestate width="7.53533268" height="2.62466669"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-M001c.jpg"><?fx-imagestate width="7.53533268" height="2.62466669"?></graphic></alternatives></inline-formula>）表示，多组间比较采用单因素方差分析法，两组间比较采用LDS-<italic>t</italic>分析法，<italic>P</italic>&lt;0.05为差异有统计学意义。</p></sec></sec><sec id="s2"><label>2</label><title>结 果</title><sec id="s2a"><label>2.1</label><title>各组小鼠心功能比较</title><p specific-use="noneIndent">与Control组比较，Model组小鼠IVSD、LVEDD和LVESD升高（均<italic>P</italic>&lt;0.01），FS和EF降低（均<italic>P</italic>&lt;0.01）；与Model组比较，TAK-242组小鼠IVSD、LVEDD和LVESD降低，FS和EF升高（均<italic>P</italic>&lt;0.01），而LPS组小鼠IVSD、LVEDD和LVESD升高，FS和EF降低（均<italic>P</italic>&lt;0.05）。与LPS组比较，LPS+DNaseⅠ组小鼠IVSD、LVEDD和LVESD降低，FS和EF升高（均<italic>P</italic>&lt;0.05）。见<xref ref-type="fig" rid="F1">图1</xref>。</p><fig position="float" id="F1"><object-id pub-id-type="doi">10.19405/j.cnki.issn1000–1492.2026.04.014.F001</object-id><label>图1</label><caption><title>各组小鼠心功能比较</title></caption><abstract abstract-type="caption" xml:lang="en"><label>Fig.1</label><title>Comparison of cardiac function of mice in each group</title></abstract><abstract abstract-type="note"><p>a： Control group； b： Model group； c： TAK-242 group； d： LPS group； e： LPS+DNase I group； <sup>**</sup><italic>P</italic>&lt;0.01 <italic>vs</italic> Control group； <sup>#</sup><italic>P</italic>&lt;0.05， <sup>##</sup><italic>P</italic>&lt;0.01<italic> vs</italic> Model group；<sup> △</sup><italic>P</italic>&lt;0.05， <sup>△△</sup><italic>P</italic>&lt;0.01<italic> vs</italic> LPS group.</p></abstract><alternatives><graphic specific-use="print" xlink:href="media/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F001.eps" id="Graphic1"><?fx-imagestate width="78.31666565" height="92.42777252"?></graphic><graphic specific-use="big" xlink:href="alternativeImage/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F001.jpg"><?fx-imagestate width="78.31666565" height="92.42777252"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F001c.jpg"><?fx-imagestate width="78.31666565" height="92.42777252"?></graphic></alternatives></fig></sec><sec id="s2b"><label>2.2</label><title>各组小鼠血清心肌损伤标志物及炎症指标水平</title><p specific-use="noneIndent">与Control组比较，Model组小鼠血清中心肌损伤标志物NT-pro BNP、cTnI及炎症指标IL-1β、IL-6、TNF-α水平升高（均<italic>P</italic>&lt;0.01）；与 Model组比较，TAK-242组小鼠血清中NT-pro BNP、cTnI、IL-1β、IL-6、TNF-α水平降低（均<italic>P</italic>&lt;0.01），而LPS处理则进一步加剧其升高（均<italic>P</italic>&lt;0.05）；与LPS组比较，LPS+DNaseⅠ组小鼠血清NT-pro BNP、cTnI及IL-1β、IL-6、TNF-α水平降低（均<italic>P</italic>&lt;0.05）。见<xref ref-type="fig" rid="F2">图2</xref>。</p><fig position="float" id="F2"><object-id pub-id-type="doi">10.19405/j.cnki.issn1000–1492.2026.04.014.F002</object-id><label>图2</label><caption><title>各组小鼠血清心肌损伤标志物及炎症指标水平</title></caption><abstract abstract-type="caption" xml:lang="en"><label>Fig.2</label><title>Levels of serum myocardial injury markers and inflammatory indicators of mice in each group</title></abstract><abstract abstract-type="note"><p>a： Control group； b： Model group； c： TAK-242 group； d： LPS group； e： LPS+DNase I group； <sup>**</sup><italic>P</italic>&lt;0.01 <italic>vs</italic> Control group； <sup>#</sup><italic>P</italic>&lt;0.05， <sup>##</sup><italic>P</italic>&lt;0.01<italic> vs</italic> Model group；<sup> △</sup><italic>P</italic>&lt;0.05， <sup>△△</sup><italic>P</italic>&lt;0.01<italic> vs</italic> LPS group.</p></abstract><alternatives><graphic specific-use="print" xlink:href="media/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F002.eps" id="Graphic2"><?fx-imagestate width="74.08333588" height="30.33888817"?></graphic><graphic specific-use="big" xlink:href="alternativeImage/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F002.jpg"><?fx-imagestate width="74.08333588" height="30.33888817"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F002c.jpg"><?fx-imagestate width="74.08333588" height="30.33888817"?></graphic></alternatives></fig></sec><sec id="s2c"><label>2.3</label><title>各组小鼠心肌组织病理学变化</title><p specific-use="noneIndent">心肌组织HE染色结果显示，Control组小鼠心肌组织结构完整，细胞排列整齐。Model组和LPS组均表现出心肌细胞数量减少，间隙增宽，组织断裂及排列紊乱。TAK-242组心肌损伤较Model组有明显改善，而LPS+DNaseⅠ联合干预也对LPS诱导的心肌损伤具有修复作用。见<xref ref-type="fig" rid="F3">图3</xref>。</p><fig position="float" id="F3"><object-id pub-id-type="doi">10.19405/j.cnki.issn1000–1492.2026.04.014.F003</object-id><label>图3</label><caption><title>各组小鼠心肌组织病理学变化    ×200</title></caption><abstract abstract-type="caption" xml:lang="en"><label>Fig.3</label><title>Histopathological changes in myocardial tissue of mice in each group    ×200</title></abstract><abstract abstract-type="note"><p>A： Control group； B： Model group； C： TAK-242 group； D： LPS group； E： LPS+DNase I group.</p></abstract><alternatives><graphic specific-use="print" xlink:href="media/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F003.eps" id="Graphic3"><?fx-imagestate width="169.79998779" height="25.31179810"?></graphic><graphic specific-use="big" xlink:href="alternativeImage/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F003.jpg"><?fx-imagestate width="169.79998779" height="25.31179810"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F003c.jpg"><?fx-imagestate width="169.79998779" height="25.31179810"?></graphic></alternatives></fig></sec><sec id="s2d"><label>2.4</label><title>各组小鼠心肌组织胶原纤维的沉淀情况</title><p specific-use="noneIndent">心肌组织Masson染色结果显示，与Control组比较，Model组小鼠心肌组织胶原纤维沉淀明显增多，提示心肌组织纤维化严重；与Model组比较，TAK-242组小鼠心肌组织胶原纤维沉淀减少，而LPS组小鼠心肌组织胶原纤维沉淀增多；与LPS组比较，LPS+DNaseⅠ组小鼠心肌组织胶原纤维沉淀减少。见<xref ref-type="fig" rid="F4">图4</xref>。</p><fig position="float" id="F4"><object-id pub-id-type="doi">10.19405/j.cnki.issn1000–1492.2026.04.014.F004</object-id><label>图4</label><caption><title>各组小鼠心肌组织胶原纤维的沉淀情况    ×200</title></caption><abstract abstract-type="caption" xml:lang="en"><label>Fig.4</label><title>Precipitation of collagen fibers in myocardial tissues of mice in each group    ×200</title></abstract><abstract abstract-type="note"><p>A： Control group； B： Model group； C： TAK-242 group； D： LPS group； E： LPS+DNase I group； Blue areas represent collagen deposition.</p></abstract><alternatives><graphic specific-use="print" xlink:href="media/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F004.eps" id="Graphic4"><?fx-imagestate width="169.79998779" height="24.96024513"?></graphic><graphic specific-use="big" xlink:href="alternativeImage/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F004.jpg"><?fx-imagestate width="169.79998779" height="24.96024513"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F004c.jpg"><?fx-imagestate width="169.79998779" height="24.96024513"?></graphic></alternatives></fig></sec><sec id="s2e"><label>2.5</label><title>各组小鼠血清及心肌组织中MPO-DNA和NE-DNA含量</title><p specific-use="noneIndent">ELISA检测各组小鼠血清和心肌组织中MPO-DNA和NE-DNA水平，结果显示，与Control组比较，Model组小鼠血清及心肌组织中MPO-DNA和NE-DNA水平升高（均<italic>P</italic>&lt;0.01）；与Model组比较，TAK-242组小鼠血清及心肌组织中MPO-DNA和NE-DNA水平降低（均<italic>P</italic>&lt;0.01），而LPS处理则进一步加剧其升高（均<italic>P</italic>&lt;0.01）；与LPS组比较，LPS+DNaseⅠ组小鼠血清及心肌组织中MPO-DNA和NE-DNA水平降低（均<italic>P</italic>&lt;0.05）。见<xref ref-type="fig" rid="F5">图5</xref>。</p><fig position="float" id="F5"><object-id pub-id-type="doi">10.19405/j.cnki.issn1000–1492.2026.04.014.F005</object-id><label>图5</label><caption><title>各组小鼠血清及心肌组织中MPO-DNA和NE-DNA水平</title></caption><abstract abstract-type="caption" xml:lang="en"><label>Fig.5</label><title>Levels of MPO-DNA and NE-DNA in the serum andmyocardial tissues of mice in each group</title></abstract><abstract abstract-type="note"><p>MPO-DNA and NE-DNA levels are presented as absorbance values measured at 450 nm. a： Control group； b： Model group； c： TAK-242 group； d： LPS group； e： LPS+DNase I group； <sup>**</sup><italic>P</italic>&lt;0.01 <italic>vs</italic> Control group； <sup>##</sup><italic>P</italic>&lt;0.01<italic> vs</italic> Model group；<sup> △</sup><italic>P</italic>&lt;0.05， <sup>△△</sup><italic>P</italic>&lt;0.01<italic> vs</italic> LPS group.</p></abstract><alternatives><graphic specific-use="print" xlink:href="media/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F005.eps" id="Graphic5"><?fx-imagestate width="70.20277405" height="41.62777328"?></graphic><graphic specific-use="big" xlink:href="alternativeImage/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F005.jpg"><?fx-imagestate width="70.20277405" height="41.62777328"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F005c.jpg"><?fx-imagestate width="70.20277405" height="41.62777328"?></graphic></alternatives></fig></sec><sec id="s2f"><label>2.6</label><title>各组小鼠心肌组织中Ly6G与MPO共定位水平</title><p specific-use="noneIndent">与Control组比较，Model组小鼠心肌组织中中性粒细胞标志物Ly6G与NETs标志物MPO共定位水平升高（<italic>P</italic>&lt;0.01）；与Model组比较，TAK-242组小鼠心肌组织中Ly6G与MPO共定位水平降低（<italic>P</italic>&lt;0.01），LPS组小鼠心肌组织中Ly6G与MPO共定位水平升高（<italic>P</italic>&lt;0.01）；与LPS组比较，LPS+DNaseⅠ组小鼠心肌组织中Ly6G与MPO共定位水平降低（<italic>P</italic>&lt;0.01）。见<xref ref-type="fig" rid="F6">图6</xref>。</p><fig position="float" id="F6"><object-id pub-id-type="doi">10.19405/j.cnki.issn1000–1492.2026.04.014.F006</object-id><label>图6</label><caption><title>各组小鼠心肌组织中Ly6G与MPO共定位水平</title></caption><abstract abstract-type="caption" xml:lang="en"><label>Fig.6</label><title>Co-localization levels of Ly6G and MPO in myocardial tissues of mice in each group</title></abstract><abstract abstract-type="note"><p>a： Control group； b： Model group； c： TAK-242 group； d： LPS group； e： LPS+DNase I group； <sup>**</sup><italic>P</italic>&lt;0.01 <italic>vs</italic> Control group； <sup>##</sup><italic>P</italic>&lt;0.01<italic> vs</italic> Model group；<sup> △△</sup><italic>P</italic>&lt;0.01<italic> vs</italic> LPS group； Bar=20 μm.</p></abstract><alternatives><graphic specific-use="print" xlink:href="media/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F006.eps" id="Graphic6"><?fx-imagestate width="159.45555115" height="109.00832367"?></graphic><graphic specific-use="big" xlink:href="alternativeImage/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F006.jpg"><?fx-imagestate width="159.45555115" height="109.00832367"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F006c.jpg"><?fx-imagestate width="159.45555115" height="109.00832367"?></graphic></alternatives></fig></sec><sec id="s2g"><label>2.7</label><title>各组小鼠心肌组织中TLR4、MPO、NE、cit-H3蛋白表达量</title><p specific-use="noneIndent">与Control组比较，Model组小鼠心肌组织中TLR4、MPO、NE、cit-H3蛋白表达量升高（均<italic>P</italic>&lt;0.01）；与Model组比较，TAK-242组小鼠心肌组织中TLR4、MPO、NE、cit-H3蛋白表达量降低（均<italic>P</italic>&lt;0.01），而LPS处理则进一步加剧其升高（均<italic>P</italic>&lt;0.01）；与LPS组比较，LPS+DNaseⅠ组小鼠心肌组织中TLR4、MPO、NE、cit-H3蛋白表达量降低（均<italic>P</italic>&lt;0.01）。见<xref ref-type="fig" rid="F7">图7</xref>。</p><fig position="float" id="F7"><object-id pub-id-type="doi">10.19405/j.cnki.issn1000–1492.2026.04.014.F007</object-id><label>图7</label><caption><title>各组小鼠心肌组织中TLR4、MPO、NE、cit-H3蛋白表达量</title></caption><abstract abstract-type="caption" xml:lang="en"><label>Fig.7</label><title>Expression levels of TLR4， MPO， NE， and cit-H3 proteins in the myocardial tissues of mice in each group</title></abstract><abstract abstract-type="note"><p>a： Control group； b： Model group； c： TAK-242 group； d： LPS group； e： LPS+DNase I group； <sup>**</sup><italic>P</italic>&lt;0.01 <italic>vs</italic> Control group； <sup>##</sup><italic>P</italic>&lt;0.01<italic> vs</italic> Model group；  <sup>△△</sup><italic>P</italic>&lt;0.01<italic> vs</italic> LPS group.</p></abstract><alternatives><graphic specific-use="print" xlink:href="media/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F007.eps" id="Graphic7"><?fx-imagestate width="154.51667786" height="50.79999924"?></graphic><graphic specific-use="big" xlink:href="alternativeImage/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F007.jpg"><?fx-imagestate width="154.51667786" height="50.79999924"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/F9B80592-0D0F-45a1-AEE2-BA6564B6CA74-F007c.jpg"><?fx-imagestate width="154.51667786" height="50.79999924"?></graphic></alternatives></fig></sec></sec><sec id="s3"><label>3</label><title>讨 论</title><p>由于人口老龄化、全球人口增长等因素，HF的患病率呈逐年上升趋势，给患者家庭和社会带来严重负担。心脏超声检查是心脏疾病诊断中的常规手段，能够直观反映患者心脏结构及功能异常。NT-pro BNP是一种主要由心室分泌的心脏激素，常被用于评估心脏功能及诊断HF等心脏疾病的严重程度<sup>［<xref ref-type="bibr" rid="R5">5</xref>］</sup>。cTnI作为心肌细胞特异性表达的调控蛋白，是心肌细胞损伤或坏死的特异性生物标志物，临床用于评估心肌损伤严重程度及心功能受损状况。ISO是一种非选择性β受体激动剂，被广泛用于诱导小鼠心脏损伤<sup>［<xref ref-type="bibr" rid="R6">6</xref>］</sup>，其中，急性给药模型可用于模拟应激诱发的心肌病，而通过渗透泵实现持续给药的慢性模型则能够更好地模拟人类HF的病理特征。本研究通过向小鼠背部皮下植入渗透微型泵，持续输注ISO，构建HF小鼠模型，结果显示Model组小鼠心肌组织病理损伤明显，心肌组织胶原纤维的沉淀增多且IVSD、LVEDD、LVESD显著增加，FS和EF显著降低，血清中心肌损伤标志物NT-pro BNP、cTnI水平显著上调，提示HF小鼠心脏结构及功能受损。</p><p>研究<sup>［<xref ref-type="bibr" rid="R7">7</xref>］</sup>显示，老龄化伴随的心肌和血管系统退行性变化及免疫系统的失调，会引发慢性低度炎症、氧化应激和代谢紊乱等症状，加速老年患者的心功能衰退。作为先天免疫反应的一部分，TLR在与HF相关的致病性炎症反应中充当激活炎性因子的上游调节因子，被认为是HF的潜在治疗靶点。心肌细胞损伤后释放的损伤相关分子被PRR（如TLR）识别，激活先天性免疫级联反应，促进炎症因子分泌。衰竭心肌组织内IL-1β、IL-6、TNF-α等炎症因子表达水平呈现病理性上调，通过促进心肌细胞凋亡、坏死，加重心肌纤维化等途径促使HF发展恶化<sup>［<xref ref-type="bibr" rid="R8">8</xref>］</sup>。进一步研究<sup>［<xref ref-type="bibr" rid="R9">9</xref>–<xref ref-type="bibr" rid="R11">11</xref>］</sup>揭示，TLR4在心肌炎症性疾病中具有关键调控作用，其异常活化可显著加剧包括HF、病毒性心肌炎、心肌梗死等多种心血管疾病的病理进程。本研究中，Model组小鼠心肌组织中TLR4蛋白表达显著升高，经TLR4抑制剂TAK-242干预后，HF小鼠心功能明显改善，炎症指标IL-1β、IL-6、TNF-α水平降低。而采用LPS干预激活TLR4信号后，HF小鼠心脏损伤加重，炎症指标进一步上调。这些结果提示，TLR4信号通路的激活参与了HF小鼠心肌炎症反应的调控，抑制TLR4表达可有效减轻心肌炎症，从而改善HF小鼠心脏功能。</p><p>NETs是中性粒细胞被激活后释放的一种胞外网状结构，属于机体抵御病原体入侵的第一道防线。Ly6G是中性粒细胞高表达的表面标志物，与MPO共定位可特异性标记中性粒细胞来源的NETs结构，直接反映NETs形成水平。过量释放的NETs通过为血小板聚集提供支架、激活凝血途径及刺激内皮细胞释放促凝物质，显著增加血栓形成和微循环障碍风险<sup>［<xref ref-type="bibr" rid="R12">12</xref>］</sup>。冠状动脉血栓可导致心肌氧供不足，引发心绞痛、心肌损伤甚至心脏骤停，同时可能诱发心脏瓣膜功能障碍，加重HF进程<sup>［<xref ref-type="bibr" rid="R13">13</xref>］</sup>。研究<sup>［<xref ref-type="bibr" rid="R14">14</xref>］</sup>表明，NETs在心肌缺血和损伤中的表达显著增高，其水平与心血管疾病的严重程度呈正相关性，其相关成分（如MPO-DNA、NE-DNA、cit-H3）已成为预测HF风险的潜在生物标志物。Zhang et al<sup>［<xref ref-type="bibr" rid="R15">15</xref>］</sup>研究显示，射血分数保留的心力衰竭患者心肌组织中cit-H3水平升高，提示NETs与HF的病理过程密切相关。本研究结果显示，TLR4抑制剂TAK-242可显著降低HF小鼠心肌MPO、NE、cit-H3蛋白表达及Ly6G<sup>+</sup>MPO<sup>+</sup>共定位水平。同时，与单独使用TLR4激动剂LPS相比，联合应用NETs抑制剂DNaseⅠ干预的HF小鼠心肌损伤显著减轻，进一步证实TLR4通过促进NETs形成加剧HF病理损伤，TLR4抑制剂可能通过下调NETs水平发挥心肌保护作用。</p></sec></body><back><ref-list><title>参考文献</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Zhang</surname><given-names>Y</given-names></name>， <name name-style="eastern"><surname>Wu</surname><given-names>J</given-names></name>， <name name-style="eastern"><surname>Dong</surname><given-names>E</given-names></name>， <etal>et al</etal></person-group>. <article-title>Toll-like receptors in cardiac hypertrophy</article-title>［J］. <source>Front Cardiovasc Med</source>， <year>2023</year>， <volume>10</volume>： <fpage>1143583</fpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.3389/fcvm.2023.1143583">10.3389/fcvm.2023.1143583</ext-link></comment>.</mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Liu</surname><given-names>H</given-names></name>， <name name-style="eastern"><surname>Chu</surname><given-names>S</given-names></name>， <name name-style="eastern"><surname>Wu</surname><given-names>Z</given-names></name></person-group>. <article-title>Loss of toll-like receptor 4 ameliorates cardiovascular dysfunction in aged mice</article-title>［J］. <source>Immun Ageing</source>， <year>2021</year>， <volume>18</volume>（<issue>1</issue>）： <fpage>42</fpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1186/s12979-021-00251-y">10.1186/s12979-021-00251-y</ext-link></comment>.</mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Zhao</surname><given-names>M</given-names></name>， <name name-style="eastern"><surname>Zheng</surname><given-names>Z</given-names></name>， <name name-style="eastern"><surname>Yin</surname><given-names>Z</given-names></name>， <etal>et al</etal></person-group>. <article-title>DEL-1 deficiency aggravates pressure overload-induced heart failure by promoting neutrophil infiltration and neutrophil extracellular traps formation</article-title>［J］. <source>Biochem Pharmacol</source>， <year>2023</year>， <volume>218</volume>： <fpage>115912</fpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1016/j.bcp.2023.115912">10.1016/j.bcp.2023.115912</ext-link></comment>.</mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Kim</surname><given-names>H J</given-names></name>， <name name-style="eastern"><surname>Kim</surname><given-names>H</given-names></name>， <name name-style="eastern"><surname>Lee</surname><given-names>J H</given-names></name>， <etal>et al</etal></person-group>. <article-title>Toll-like receptor 4 （TLR4）： new insight immune and aging</article-title>［J］. <source>Immun Ageing</source>， <year>2023</year>， <volume>20</volume>（<issue>1</issue>）： <fpage>67</fpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1186/s12979-023-00383-3">10.1186/s12979-023-00383-3</ext-link></comment>.</mixed-citation></ref><ref id="R5"><label>5</label><citation-alternatives><mixed-citation publication-type="journal" publication-format="print"><person-group><string-name>陈方圆</string-name>， <string-name>焦长青</string-name>， <string-name>黎　冉</string-name>， <etal>等</etal></person-group>. <article-title>BNP水平联合心脏结构指标对高血压伴HFREF的临床预测价值</article-title>［J］. <source>安徽医科大学学报</source>， <year>2021</year>， <volume>56</volume>（<issue>3</issue>）： <fpage>471</fpage>-<lpage>5</lpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.19405/j.cnki.issn1000-1492.2021.03.027">10.19405/j.cnki.issn1000-1492.2021.03.027</ext-link></comment>.</mixed-citation><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Chen</surname><given-names>F Y</given-names></name>， <name name-style="eastern"><surname>Jiao</surname><given-names>C Q</given-names></name>， <name name-style="eastern"><surname>Li</surname><given-names>R</given-names></name>， <etal>et al</etal></person-group>. <article-title>Clinical prediction value of BNP combined with LAD and LVEDD in hypertension patients with heart failure</article-title>［J］. <source>Acta Univ Med Anhui</source>， <year>2021</year>， <volume>56</volume>（<issue>3</issue>）： <fpage>471</fpage>-<lpage>5</lpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.19405/j.cnki.issn1000-1492.2021.03.027">10.19405/j.cnki.issn1000-1492.2021.03.027</ext-link></comment>.</mixed-citation></citation-alternatives></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Baburina</surname><given-names>Y</given-names></name>， <name name-style="eastern"><surname>Krestinin</surname><given-names>R</given-names></name>， <name name-style="eastern"><surname>Fedorov</surname><given-names>D</given-names></name>， <etal>et al</etal></person-group>. <article-title>The improvement of functional state of brain mitochondria with astaxanthin in rats after heart failure</article-title>［J］. <source>Int J Mol Sci</source>， <year>2022</year>， <volume>24</volume>（<issue>1</issue>）：<fpage>31</fpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.3390/ijms24010031">10.3390/ijms24010031</ext-link></comment>.</mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Ji</surname><given-names>H</given-names></name>， <name name-style="eastern"><surname>Kwan</surname><given-names>A C</given-names></name>， <name name-style="eastern"><surname>Chen</surname><given-names>M T</given-names></name>， <etal>et al</etal></person-group>. <article-title>Sex differences in myocardial and vascular aging</article-title>［J］. <source>Circ Res</source>， <year>2022</year>， <volume>130</volume>（<issue>4</issue>）： <fpage>566</fpage>-<lpage>77</lpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1161/CIRCRESAHA.121.319902">10.1161/CIRCRESAHA.121.319902</ext-link></comment>.</mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Li</surname><given-names>J</given-names></name>， <name name-style="eastern"><surname>Wang</surname><given-names>M</given-names></name>， <name name-style="eastern"><surname>Yao</surname><given-names>L</given-names></name>， <etal>et al</etal></person-group>. <article-title>Yixin granules reduce myocardial inflammation and fibrosis in rats with heart failure by inhibiting the expression of ADAMTS8</article-title>［J］. <source>Int Heart J</source>， <year>2023</year>， <volume>64</volume>（<issue>4</issue>）： <fpage>741</fpage>-<lpage>9</lpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1536/ihj.22-715">10.1536/ihj.22-715</ext-link></comment>.</mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Vaez</surname><given-names>H</given-names></name>， <name name-style="eastern"><surname>Soraya</surname><given-names>H</given-names></name>， <name name-style="eastern"><surname>Garjani</surname><given-names>A</given-names></name>， <etal>et al</etal></person-group>. <article-title>Toll-like receptor 4 （TLR4） and AMPK relevance in cardiovascular disease</article-title>［J］. <source>Adv Pharm Bull</source>， <year>2023</year>， <volume>13</volume>（<issue>1</issue>）： <fpage>36</fpage>-<lpage>47</lpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.34172/apb.2023.004">10.34172/apb.2023.004</ext-link></comment>.</mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Tao</surname><given-names>D D</given-names></name>， <name name-style="eastern"><surname>Li</surname><given-names>Y</given-names></name>， <name name-style="eastern"><surname>Tian</surname><given-names>X J</given-names></name>， <etal>et al</etal></person-group>. <article-title>Effect of FoxO1 on cardiomyocyte apoptosis and inflammation in viral myocarditis <italic>via</italic> modultion of the TLR4/NF-κB signaling pathway</article-title>［J］. <source>Int Heart J</source>， <year>2023</year>， <volume>64</volume>（<issue>4</issue>）： <fpage>732</fpage>-<lpage>40</lpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1536/ihj.22-627">10.1536/ihj.22-627</ext-link></comment>.</mixed-citation></ref><ref id="R11"><label>11</label><citation-alternatives><mixed-citation publication-type="journal" publication-format="print"><person-group><string-name>胡楚婷</string-name>， <string-name>宋　煜</string-name>， <string-name>王　琳</string-name></person-group>. <article-title>TLR4参与急性心肌梗死及其治疗的研究进展</article-title>［J］. <source>中国动脉硬化杂志</source>， <year>2024</year>， <volume>32</volume>（<issue>8</issue>）： <fpage>705</fpage>-<lpage>11</lpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.20039/j.cnki.1007-3949.2024.08.009">10.20039/j.cnki.1007-3949.2024.08.009</ext-link></comment>.</mixed-citation><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Hu</surname><given-names>C T</given-names></name>， <name name-style="eastern"><surname>Song</surname><given-names>Y</given-names></name>， <name name-style="eastern"><surname>Wang</surname><given-names>L</given-names></name></person-group>. <article-title>Research progress of TLR4 in acute myocardial infarction and its treatment</article-title>［J］. <source>Chin J Arterioscler</source>， <year>2024</year>， <volume>32</volume>（<issue>8</issue>）： <fpage>705</fpage>-<lpage>11</lpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.20039/j.cnki.1007-3949.2024.08.009">10.20039/j.cnki.1007-3949.2024.08.009</ext-link></comment>.</mixed-citation></citation-alternatives></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Ronchetti</surname><given-names>L</given-names></name>， <name name-style="eastern"><surname>Terrenato</surname><given-names>I</given-names></name>， <name name-style="eastern"><surname>Ferretti</surname><given-names>M</given-names></name>， <etal>et al</etal></person-group>. <article-title>Correction： circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer</article-title>［J］. <source>J Exp Clin Cancer Res</source>， <year>2023</year>， <volume>42</volume>（<issue>1</issue>）： <fpage>278</fpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1186/s13046-023-02826-7">10.1186/s13046-023-02826-7</ext-link></comment>.</mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Carnevale</surname><given-names>R</given-names></name>， <name name-style="eastern"><surname>Sciarretta</surname><given-names>S</given-names></name>， <name name-style="eastern"><surname>Valenti</surname><given-names>V</given-names></name>， <etal>et al</etal></person-group>. <article-title>Low-grade endotoxaemia enhances artery thrombus growth <italic>via</italic> Toll-like receptor 4： implication for myocardial infarction</article-title>［J］. <source>Eur Heart J</source>， <year>2020</year>， <volume>41</volume>（<issue>33</issue>）： <fpage>3156</fpage>-<lpage>65</lpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1093/eurheartj/ehz893">10.1093/eurheartj/ehz893</ext-link></comment>.</mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Carminita</surname><given-names>E</given-names></name>， <name name-style="eastern"><surname>Crescence</surname><given-names>L</given-names></name>， <name name-style="eastern"><surname>Panicot-Dubois</surname><given-names>L</given-names></name>， <etal>et al</etal></person-group>. <article-title>Role of neutrophils and NETs in animal models of thrombosis</article-title>［J］. <source>Int J Mol Sci</source>， <year>2022</year>， <volume>23</volume>（<issue>3</issue>）： <fpage>1411</fpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.3390/ijms23031411">10.3390/ijms23031411</ext-link></comment>.</mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Zhang</surname><given-names>X L</given-names></name>， <name name-style="eastern"><surname>Wang</surname><given-names>T Y</given-names></name>， <name name-style="eastern"><surname>Chen</surname><given-names>Z</given-names></name>， <etal>et al</etal></person-group>. <article-title>HMGB1-promoted neutrophil extracellular traps contribute to cardiac diastolic dysfunction in mice</article-title>［J］. <source>J Am Heart Assoc</source>， <year>2022</year>， <volume>11</volume>（<issue>4</issue>）： <elocation-id>e023800</elocation-id>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1161/JAHA.121.023800">10.1161/JAHA.121.023800</ext-link></comment>.</mixed-citation></ref></ref-list><fn-group><fn fn-type="other" specific-use="citation-format"><p>刘焕, 陈向东, 吴志林. TLR4介导的NETs形成在异丙肾上腺素诱导的老龄小鼠心力衰竭中的作用[J]. 安徽医科大学学报, 2026, 61(04): 699-705.</p></fn><fn fn-type="other" specific-use="citation-format" xml:lang="en"><p>Liu Huan, Chen Xiangdong, Wu Zhilin. Role of TLR4-mediated NETs formation in isoproterenol-induced heart failure in aged mice[J]. Acta Universitatis Medicinalis Anhui, 2026, 61(04): 699-705.</p></fn></fn-group></back><?original-text name="authorName-zh" content="刘  焕<sup>1，2，3</sup>，陈向东<sup>1，2，3</sup>，吴志林<sup>1，2，3</sup>"?><?original-text name="authorAff-zh" content="［华中科技大学同济医学院附属协和医院<sup>1</sup>麻醉科、<sup>2</sup>麻醉与危重病研究所，武汉  430022；<sup>3</sup>麻醉复苏教育部重点实验室（华中科技大学），武汉  430022］"?><?original-text name="authorName-en" content="Liu Huan<sup>1， 2， 3</sup>， Chen Xiangdong<sup>1， 2， 3</sup>， Wu Zhilin<sup>1， 2， 3</sup>"?><?original-text name="authorAff-en" content="（<sup>1</sup>Dept of Anesthesiology， <sup>2</sup>Institute of Anesthesia and Critical Care Medicine， Union Hospital， Tongji Medical College， Huazhong University of Science and Technology， Wuhan     430022； <sup>3</sup>Key Laboratory of Anesthesiology and Resuscitation， Ministry of Education， Huazhong University of Science and Technology， Wuhan     430022）"?></article>